Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 065054
Company: MAYNE PHARMA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CYCLOSPORINE CYCLOSPORINE 100MG/ML SOLUTION;ORAL Prescription AB1 No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/18/2001 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
01/20/2015 SUPPL-19 Labeling-Package Insert

Label is not available on this site.

11/16/2007 SUPPL-10 Labeling

Label is not available on this site.

02/05/2007 SUPPL-8 Labeling

Label is not available on this site.

12/02/2004 SUPPL-4 Labeling

Label is not available on this site.

05/14/2004 SUPPL-3 Labeling

Label is not available on this site.

05/03/2002 SUPPL-2 Labeling

Label is not available on this site.

05/03/2002 SUPPL-1 Labeling

Label is not available on this site.

CYCLOSPORINE

SOLUTION;ORAL; 100MG/ML
TE Code = AB1

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CYCLOSPORINE CYCLOSPORINE 100MG/ML SOLUTION;ORAL Prescription No AB1 065025 ABBVIE
CYCLOSPORINE CYCLOSPORINE 100MG/ML SOLUTION;ORAL Prescription No AB1 065078 IVAX SUB TEVA PHARMS
CYCLOSPORINE CYCLOSPORINE 100MG/ML SOLUTION;ORAL Prescription No AB1 065054 MAYNE PHARMA
NEORAL CYCLOSPORINE 100MG/ML SOLUTION;ORAL Prescription Yes AB1 050716 NOVARTIS

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English